Department of Pediatrics, UCLA Medical Center, Los Angeles, CA, USA.
Circ Arrhythm Electrophysiol. 2011 Feb;4(1):73-8. doi: 10.1161/CIRCEP.110.958660. Epub 2010 Dec 14.
Rapid anterograde conduction in the setting of ventricular preexcitation is associated with an increased risk of sudden cardiac death. The effect of isoproterenol in this setting is unclear, particularly in younger anesthetized patients. The aim of this study was to determine the effect of isoproterenol on accessory-pathway conduction in children undergoing general anesthesia and its role in the risk-stratification process.
The records of 151 pediatric patients with preexcitation undergoing electrophysiologic study under propofol anesthesia during a 5-year period were reviewed. Data included accessory-pathway effective refractory period, minimum 1:1 accessory pathway conduction with atrial pacing, and shortest preexcited R-R interval in atrial fibrillation. Measurements were repeated after administration of low-dose isoproterenol (mean, 0.013 μg/kg per min; range, 0.003 to 0.027). All accessory-pathway characteristics were significantly shortened with isoproterenol (P<0.001). Accessory-pathway effective refractory period increased modestly with age, both in the baseline state (r=0.172, P=0.04) and with isoproterenol (r=0.267, P<0.01) as did minimum 1:1 accessory pathway conduction with atrial pacing (r=0.178, P=0.034, and r=0.175, P<0.01, respectively). Accessory-pathway effective refractory period ≤250 ms was observed in only 5% of patients at baseline vs 25% after isoproterenol, and Shortest preexcited R-R interval in atrial fibrillation ≤250 ms was noted in 16% vs 41%. Tachycardia was induced in 48 of 151 patients before and in 102 of 151 after isoproterenol.
In anesthetized children with ventricular preexcitation, accessory pathways display shorter conduction properties at younger ages and important adrenergic sensitivity at all ages. Use of low-dose isoproterenol resulted in a substantial increase in the number of patients who would otherwise meet typical criteria for ablation.
在心室预激的情况下,快速前向传导与心脏性猝死风险增加相关。异丙肾上腺素在此情况下的作用尚不清楚,尤其是在年轻的麻醉患者中。本研究旨在确定异丙肾上腺素对接受全身麻醉的儿童旁道传导的影响及其在风险分层过程中的作用。
回顾了 151 例在丙泊酚麻醉下进行电生理研究的预激患儿的记录。数据包括旁道有效不应期、心房起搏时最短的 1:1 旁道传导和心房颤动时最短的预激 R-R 间期。在给予低剂量异丙肾上腺素(平均 0.013μg/kg/min;范围 0.003 至 0.027)后重复测量。所有旁道特征均随异丙肾上腺素而显著缩短(P<0.001)。旁道有效不应期随年龄适度增加,无论是在基础状态下(r=0.172,P=0.04)还是在异丙肾上腺素状态下(r=0.267,P<0.01),心房起搏时最短的 1:1 旁道传导也随年龄增加(r=0.178,P=0.034 和 r=0.175,P<0.01)。仅在基础状态下,5%的患者旁道有效不应期≤250ms,而在给予异丙肾上腺素后,25%的患者旁道有效不应期≤250ms,心房颤动时最短的预激 R-R 间期≤250ms,在基础状态下为 16%,在给予异丙肾上腺素后为 41%。在 151 例患者中,有 48 例在给予异丙肾上腺素前发生心动过速,102 例在给予异丙肾上腺素后发生心动过速。
在有心室预激的麻醉儿童中,旁道在较小年龄时表现出较短的传导特性,在所有年龄时均具有重要的肾上腺素敏感性。使用低剂量异丙肾上腺素会导致更多的患者符合消融的典型标准。